Back
Greystone Housing Impact Investors LP Vs. Monopar Therapeutics Industry Stock Comparison
Buy
56
GHI
Greystone Housing Impact Investors LP
Last Price:
$13.05
Seasonality Move:
-1.72%
Sell
45
MNPR
Monopar Therapeutics
Last Price:
$39.96
Seasonality Move:
-24.75%
Buy
56
Greystone Housing Impact Investors LP (GHI)
is a Buy
Is Greystone Housing Impact Investors LP a Buy, Sell or Hold?
-
The current Greystone Housing Impact Investors LP [GHI] share price is $13.15. The Score for GHI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
GHI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $34.37. The Score for MNPR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GHI Stock Price Chart
What is Greystone Housing Impact Investors LP's stock price today?
-
The Greystone Housing Impact Investors LP share price today is $13.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GHI is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $34.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
GHI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 61.28 | Buy |
Chaikin Money Flow: | 2485 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.39 - 12.93) | Buy |
Bollinger Bands (100): | (11.14 - 12.7) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.8 | Sell |
Relative Strength Index (14 RSI): | 50.93 | Buy |
Chaikin Money Flow: | 16181 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.38 - 44.94) | Sell |
Bollinger Bands (100): | (16.76 - 38.26) | Buy |
GHI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.83 | Buy |
20-day SMA: | 12.63 | Buy |
50-day SMA: | 12.2 | Buy |
200-day SMA: | 13.09 | Buy |
8-day EMA: | 12.84 | Buy |
20-day EMA: | 12.66 | Buy |
50-day EMA: | 12.35 | Buy |
200-day EMA: | 13.06 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.92 | Buy |
20-day SMA: | 34.11 | Buy |
50-day SMA: | 35.31 | Sell |
200-day SMA: | 15.6 | Buy |
8-day EMA: | 32.1 | Buy |
20-day EMA: | 33.86 | Buy |
50-day EMA: | 33.39 | Buy |
200-day EMA: | 20.23 | Buy |
Greystone Housing Impact Investors LP Earnings Growth & GHI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.03 per share, an increase this year of $0.19 per share, and an increase next year of $0.03 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Greystone Housing Impact Investors LP Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |